Prostate cancer is a global cancer burden and considerable effort has been made through
the years to identify biomarkers for the disease. Approximately a decade ago, the potential of …

Growing bodies of evidence have demonstrated that the identification of prostate cancer
(PCa) biomarkers in the patients' blood and urine may remarkably improve PCa diagnosis …

Rigorous measures are required to cope with the advance of extracellular vesicle (EV)
research, from 183 studies published in 2012 to 2,309 studies published in 2020. The …

Current diagnostic tools for prostate cancer (PCa) diagnosis and risk stratification are
insufficient. The hidden onset and poor efficacy of traditional therapies against metastatic …

Exosomes are a heterogeneous subset of extracellular vesicles (EVs) that biogenesis from
endosomes. Besides, exosomes contain a variety of molecular cargoes including proteins …

Background Porcine seminal plasma (SP) is endowed with a heterogeneous population of
extracellular vesicles (sEVs). This study evaluated the immunophenotypic profile by high …

Extracellular vesicles (EVs) are lipid bilayer nanovesicles released by most functional cells
to body fluids, containing bioactive molecules, mainly proteins, lipids, and nucleic acids …

Liver diseases, such as viral hepatitis, alcoholic hepatitis and cirrhosis, nonalcoholic
steatohepatitis, and hepatocellular carcinoma place a heavy burden on many patients …

Extracellular vesicles (EVs) have been regarded as one of the most potential diagnostic
biomarkers for different cancers, due to their unique physiological and pathological …

Currently, sensitive and specific methods for the detection and prognosis of early stage PCa
are lacking. To establish the diagnosis and further identify an appropriate treatment strategy …